Well Care Compounding Pharmacy product recalled over sterility concerns
- Recall date
- May 17, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Well Care Compounding Pharmacy recalls MB 12/HXB 12/FA/P5P/(LIDO 0.1 %), 2MG/2MCi/20MG/6.5MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmac…
- Recall number
- D-0997-2016
- FDA classification
- Class II
- Brand / firm
- Well Care Compounding Pharmacy
- Sold / distributed
- NV
Why it was recalled
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MB 12/HXB 12/FA/P5P/(LIDO 0.1 %), 2MG/2MCi/20MG/6.5MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121
Get recall alerts
Free email alert whenever Well Care Compounding Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Well Care Compounding Pharmacy